法国慢性病患者的百日咳住院率与费用:2008至2020年回顾性分析
该研究基于法国国家健康数据系统,分析2008至2020年10,893例百日咳住院患者,发现慢性病(尤其哮喘和/或COPD)与更高的累积住院发病率相关。儿童青少年中免疫抑制状态者调整累积发病率比最高,成人中哮喘和/或COPD者最高。免疫抑制患者住院费用中位数最高。
要点
- 慢性病患者百日咳住院累积发病率更高,成人哮喘和/或COPD者调整CIR达18.6。
- 儿童青少年免疫抑制者调整CIR为3.6,为其中最高。
- 免疫抑制患者住院费用中位数最高(4,401欧元)。
核心结论
- 慢性病与法国百日咳相关住院的更高累积发病率相关。
研究设计与样本
- 基于法国国家健康数据系统(SNDS)的回顾性分析,纳入2008至2020年10,893例百日咳住院患者。
主要发现
- 7,212例儿童青少年中1,263例(17.5%)有哮喘,68例(0.9%)有免疫抑制状态。
- 3,681例成人中2,297例(62.4%)有哮喘和/或COPD,594例(16.1%)有免疫抑制状态,454例(12.3%)有糖尿病。
- 儿童青少年中免疫抑制状态者调整CIR=3.6(95%CI:2.8-4.6),为最高。
- 成人中哮喘和/或COPD者调整CIR=18.6(95%CI:17.4-19.9),为最高。
- 免疫抑制状态患者住院费用中位数最高(4,401欧元)。
关键数值与推荐
- 儿童青少年免疫抑制状态者调整CIR=3.6(95%CI:2.8-4.6)。
- 成人哮喘和/或COPD者调整CIR=18.6(95%CI:17.4-19.9)。
- 免疫抑制状态患者住院费用中位数4,401欧元。
临床怎么用
- 应加强疫苗接种规划以减少百日咳传播,尤其针对慢性病患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDIn European countries, including France, the incidence and costs of whooping cough in people with chronic conditions remains understudied.AIMWe aimed to estimate cumulative incidence and costs of whooping cough hospitalisations in children, adolescents and adults with chronic conditions in France.METHODSWe extracted data from patients hospitalised with whooping cough with or without underlying chronic conditions, asthma, chronic obstructive pulmonary disease (COPD), diabetes and immunocompromising conditions between 2008 and 2020 using the Système National des Données de Santé (SNDS).RESULTSAmong the 10,893 patients hospitalised with whooping cough in 2008-2020, asthma and/or COPD were the most common chronic conditions. Of the 7,212 children and adolescents hospitalised, 1,263 (17.5%) had asthma and 68 (0.9%) had an immunocompromising condition. Of the 3,681 adults, 2,297 (62.4%) had asthma and/or COPD, 594 (16.1%) had an immunocompromising condition and 454 (12.3%) had diabetes. In children and adolescents, the highest cumulative incidence ratio (CIR) was among patients with an immunocompromising condition (adjusted CIR = 3.6; 95% confidence interval (CI): 2.8-4.6) whereas in adults, patients with asthma and/or COPD had the highest adjusted CIR (18.6; 95% CI: 17.4-19.9). Median hospitalisation costs were the highest for patients with an immunocompromising condition (EUR 4,401). No significant changes in healthcare resource utilisation were observed before and after whooping cough hospitalisation in adults.CONCLUSIONChronic conditions are associated with higher cumulative incidence of whooping cough-related hospitalisation in France. This highlights the importance of reducing whooping cough circulation, through strengthening vaccination programmes, particularly for those with chronic conditions.
引用
- Vargas-Zambrano JC, Arnaud M, Antunes A, et al. Whooping cough hospitalisations among patients with chronic conditions: a retrospective analysis of incidence and costs, France, 2008 to 2020. Euro Surveill. 2026. PMID: 42596896. doi:10.2807/1560-7917.ES.2026.31.32.2500561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。